Novel coumarin chalcone derivatives: synthesis, docking, and antimicrobial evaluation
DOI:
https://doi.org/10.69857/joapr.v13i1.838Keywords:
DNA gyrase, antimicrobial, coumarin, chalcone, molecular docking, ADMETAbstract
Background: This study synthesized and evaluated a series of coumarin chalcones for their antimicrobial efficacy against microbial and fungal strains. Methodology: Ten new coumarin chalcones were prepared by Claisen- Schmidt condensation by using 4-hydroxy coumarin as a precursor and followed by refluxing obtained intermediate (3-(4-aminophenyl)-3-oxo prop-1-enyl)-4-hydroxy-2H-chromen-one) with substituted aromatic benzaldehyde in the presence of piperidine as a catalyst. IR, 1HNMR, 13CNMR, and GCMS characterized all synthesized compounds. The agar well diffusion method assessed these compounds for antimicrobial activity against various bacterial and fungal strains such as E. coli, P. aeruginosa, B. subtills, S. aureus, and C. albicans. Zone inhibition was measured for each compound (10µL) against all strains. Results and Discussion: The study showed that derivatives 4c, 4e, 4f, and 4g showed strong potential for inhibition towards various fungal and microbial strains. The inhibition zone for 4c and 4e was emerged as 5.48±0.448, 7.02±0.332, 5.62±0.321, 6.81±0.021, 7.72±0.421 and 5.13±0.179, 6.76±0.511, 4.24±0.273, 4.64±0.231, 5.48±0.049 while compound 4f and 4g showed 5.40±0.420, 6.69±0.168, 5.71±0.245, 5.28±0.042, 7.09±0.175, and 4.94±0.814, 6.58±.0160, 6.01±0.455, 6.61±0.021, 6.91±0.414 mm, respectively. Between -7.1 to -10.2Kcal/mol is the range of docking score of derivatives by interactions of DNA gyrase and compounds analyzed. Here, compound 4g exhibited the highest DNA gyrase inhibition, and compound 4c exhibited a strong inhibition with docking scores of -10.2 kcal/mol and -9.8 kcal/mol, respectively. Conclusion: The findings of this work contribute to a better understanding the potential of synthesised compounds as drug candidate against microbial infections through ADMET study.
Downloads
References
Dasari B, Jimmidi R, Arya P. Selected hybrid natural products as tubulin modulators. Eur. J. Med. Chem., 94, 497–508 (2015) https://doi.org/10.1016/j.ejmech.2014.10.062.
Vazquez-Rodriguez S, Lama López R, Matos MJ, Armesto-Quintas G, Serra S, Uriarte E, Santana L, Borges F, Muñoz Crego A, Santos Y. Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis. Bioorganic Med. Chem., 23, 7045–52 (2015) https://doi.org/10.1016/j.bmc.2015.09.028.
Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res. Int., 2013, (2013) https://doi.org/10.1155/2013/963248.
Kurt BZ, Gazioglu I, Sonmez F, Kucukislamoglu M. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives. Bioorg Chem, 59, 80-90 (2015) https://doi.org/10.1016/j.bioorg.2015.02.002
Rohman N, Ardiansah B, Wukirsari T, Judeh Z. Recent Trends in the Synthesis and Bioactivity of Coumarin, Coumarin–Chalcone, and Coumarin–Triazole Molecular Hybrids. Molecules, 29, (2024) https://doi.org/10.3390/molecules29051026.
Kontogiorgis CA, Hadjipavlou-Litina DJ. Synthesis and antiinflammatory activity of coumarin derivatives. J. Med. Chem., 48, 6400–8 (2005) https://doi.org/10.1021/jm0580149.
Ngaini Z, Jefferi M. Synthesis, molecular docking, ADMET studies and antimicrobial activities of coumarin-chalcone hybrid derivatives. Nat. Prod. Res., 1–10 (2024) https://doi.org/10.1080/14786419.2024.2422524.
Sharifi-Rad J, Cruz-Martins N, López-Jornet P, Lopez EPF, Harun N, Yeskaliyeva B, Beyatli A, Sytar O, Shaheen S, Sharopov F, Taheri Y, Docea AO, Calina D, Cho WC. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms. Oxid. Med. Cell. Longev., 2021, (2021) https://doi.org/10.1155/2021/6492346.
Breijyeh Z, Jubeh B, Karaman R. Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules, 25, 1340 (2020) https://doi.org/10.3390/molecules25061340
Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect. Medicin. Chem., 25–64 (2014) https://doi.org/10.4137/PMC.S14459.
Mohammed AY, Ahamed LS. Synthesis and Characterization of New Substituted Coumarin Derivatives and Study Their Biological Activity. Chem. Methodol., 6, 813–22 (2022) https://doi.org/10.22034/CHEMM.2022.349124.1569.
Sashidhara K V., Palnati GR, Sonkar R, Avula SR, Awasthi C, Bhatia G. Coumarin chalcone fibrates: A new structural class of lipid lowering agents. Eur. J. Med. Chem., 64, 422–31 (2013) https://doi.org/10.1016/j.ejmech.2013.04.026.
Konidala SK, Kotra V, Danduga RCSR, Kola PK. Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking. Bioorg. Chem., 104, 104207 (2020) https://doi.org/10.1016/j.bioorg.2020.104207.
Wei H, Ruan J, Zhang X. Coumarin-chalcone hybrids: Promising agents with diverse pharmacological properties. RSC Adv., 6, 10846–60 (2016) https://doi.org/10.1039/c5ra26294a.
Yadav S, Kumar N, Bhalla V. Synthesis and evaluation of novel 4-anilinocoumarin derivatives as potential antimicrobial agents. J. Appl. Pharm. Sci., 12, 196–204 (2022) https://doi.org/10.7324/JAPS.2022.120518.
Srikrishna D, Dubey PK. Efficient stepwise and one pot three-component synthesis of 2-amino-4-(2-oxo-2H-chromen-3-yl)thiophene-3-carbonitriles. Tetrahedron Lett., 55, 6561–6 (2014) https://doi.org/10.1016/j.tetlet.2014.10.021.
Badreddin Musatat A, Kılıccıoglu İ, Kurman Y, Dulger G, Alpay M, Yagcı R, Atahan A DS. Antimicrobial, Antiproliferative Effects and Docking Studies of Methoxy Group Enriched Coumarin-Chalcone Hybrids. 2023 Mar;20(3):e202200973. doi: Chem Biodivers., 20, (2023) https://doi.org/10.1002/cbdv.202200973.
Prasad RK, Loksh KR. Synthesis and anti-oxidant activity of coumarinyl chalcones. Futur. J. Pharm. Sci., 7, 1–12 (2021) https://doi.org/10.1186/s43094-021-00340-1.
Yadav S, Kumar N, Bhalla V. Synthesis and evaluation of novel 4-anilinocoumarin derivatives as potential antimicrobial agents. J. Appl. Pharm. Sci., 12, 196–204 (2022) https://doi.org/10.7324/JAPS.2022.120518.
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 31, 455–61 (2010) https://doi.org/10.1002/jcc.21334.
Morris, M G, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 19, 1639–62 (1998) https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
Al-Khodairy F, Kalim Ahmad Khan M, Kunhi M, Manogaran Pulicat S, Al-Khodairy FM, Kalim Khan MA, Kunhi M, Pulicat MS, Akhtar S, Arif JM. In Silico Prediction of Mechanism of Erysolin-induced Apoptosis in Human Breast Cancer Cell Lines. Am. J. Bioinforma. Res., 2013, 62–71 (2013) https://doi.org/10.5923/j.bioinformatics.20130303.03.
Reece RJ, Maxwell A, Wang JC. DNA gyrase: Structure and function. Crit. Rev. Biochem. Mol. Biol., 26, 335–75 (1991) https://doi.org/10.3109/10409239109114072.
Collin F, Karkare S, Maxwell A. Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl. Microbiol. Biotechnol., 92, 479–97 (2011) https://doi.org/10.1007/s00253-011-3557-z.
Sood D, Kumar N, Singh A, Sakharkar MK, Tomar V, Chandra R. Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach. Genomics Inform., 16, 44–51 (2018) https://doi.org/10.5808/gi.2018.16.3.44.
Lagorce D, Douguet D, Miteva MA, Villoutreix BO. Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci. Rep., 7, 46277 (2017) https://doi.org/10.1038/srep46277.
Moya-Alvarado G, Yañez O, Morales N, González-González A, Areche C, Núñez MT, Fierro A, García-Beltrán O. Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies. Molecules, 26, (2021) https://doi.org/10.3390/molecules26092430.
Moodley T, Momin M, Mocktar C, Kannigadu C, Koorbanally NA. The synthesis, structural elucidation and antimicrobial activity of 2- and 4-substituted-coumarinyl chalcones. Magn. Reson. Chem., 54, 610–7 (2016) https://doi.org/10.1002/mrc.4414.
Bensalah D, Amri N, Mukhrish YE, Koko WS, Hamdi N. Synthesis and pharmacological properties of coumarin‐chalcones. MethodsX, 11, 102488 (2023) https://doi.org/10.1016/j.mex.2023.102488.
Salam MA, Al-Amin MY, Pawar JS, Akhter N, Lucy IB. Conventional methods and future trends in antimicrobial susceptibility testing. Saudi J. Biol. Sci., 30, 103582 (2023) https://doi.org/10.1016/j.sjbs.2023.103582.
Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis: A brief review. Virulence, 5, 213–8 (2014) https://doi.org/10.4161/viru.27024.
Feng D, Zhang A, Yang Y, Yang P. Coumarin-containing hybrids and their antibacterial activities. Arch. Pharm. (Weinheim)., 353, 1–12 (2020) https://doi.org/10.1002/ardp.201900380.
Zhu JK, Gao JM, Yang CJ, Shang XF, Zhao ZM, Lawoe RK, Zhou R, Sun Y, Yin XD, Liu YQ. Design, Synthesis, and Antifungal Evaluation of Neocryptolepine Derivatives against Phytopathogenic Fungi. J. Agric. Food Chem., 68, 2306–15 (2020) https://doi.org/10.1021/acs.jafc.9b06793.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Sumita Kumari, Amit Sharma, Sonia Yadav
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
